BIOMAT Database Logo BIOMAT Database Logo

L-cysteine administration prevents liver fibrosis by suppressing hepatic stellate cell proliferation and activation. 2003

Takashi Horie, and Isao Sakaida, and Fumihiko Yokoya, and Megumi Nakajo, and Ichiro Sonaka, and Kiwamu Okita
Pharmaceuticals Research Laboratories, Ajinomoto Co, Inc, 1-1, Suzuki-cho, Kawasaki-ku, Kawasaki 210-8681, Japan.

Recent studies showed that the function of some amino acids is not only nutritional but also pharmacological. However, the effects of amino acids on liver fibrosis and hepatic stellate cell (HSC) remain unclear. In this research, as a result of screening of amino acids using liver fibrosis induced by DMN administration, L-cysteine was selected as a suppressor of liver fibrosis. Furthermore, the number of activated HSCs, which increased in the fibrotic liver after DMN administration, was decreased in L-cysteine-fed rats. Treatment of freshly isolated HSCs with L-cysteine resulted in inhibition of the increase in smooth muscle alpha-actin (alphaSMA) expression by HSCs and BrdU incorporation into the activated HSCs. These findings suggest that L-cysteine is effective against liver fibrosis. The mechanism of inhibition of fibrosis in the liver is surmized to be direct inhibition of activated HSC proliferation and HSC transformation by L-cysteine.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003545 Cysteine A thiol-containing non-essential amino acid that is oxidized to form CYSTINE. Cysteine Hydrochloride,Half-Cystine,L-Cysteine,Zinc Cysteinate,Half Cystine,L Cysteine
D004128 Dimethylnitrosamine A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties. It causes serious liver damage and is a hepatocarcinogen in rodents. Nitrosodimethylamine,N-Nitrosodimethylamine,NDMA Nitrosodimethylamine,N Nitrosodimethylamine,Nitrosodimethylamine, NDMA
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

Takashi Horie, and Isao Sakaida, and Fumihiko Yokoya, and Megumi Nakajo, and Ichiro Sonaka, and Kiwamu Okita
Curcumin prevents liver fibrosis by inducing apoptosis and suppressing activation of hepatic stellate cells.
October 2009, Journal of natural medicines,
Takashi Horie, and Isao Sakaida, and Fumihiko Yokoya, and Megumi Nakajo, and Ichiro Sonaka, and Kiwamu Okita
Berberine inhibits hepatic stellate cell proliferation and prevents experimental liver fibrosis.
September 2009, Biological & pharmaceutical bulletin,
Takashi Horie, and Isao Sakaida, and Fumihiko Yokoya, and Megumi Nakajo, and Ichiro Sonaka, and Kiwamu Okita
Polydatin attenuates hepatic stellate cell proliferation and liver fibrosis by suppressing sphingosine kinase 1.
October 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Takashi Horie, and Isao Sakaida, and Fumihiko Yokoya, and Megumi Nakajo, and Ichiro Sonaka, and Kiwamu Okita
Fluorofenidone attenuates hepatic fibrosis by suppressing the proliferation and activation of hepatic stellate cells.
February 2014, American journal of physiology. Gastrointestinal and liver physiology,
Takashi Horie, and Isao Sakaida, and Fumihiko Yokoya, and Megumi Nakajo, and Ichiro Sonaka, and Kiwamu Okita
Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability.
July 2022, BMC pharmacology & toxicology,
Takashi Horie, and Isao Sakaida, and Fumihiko Yokoya, and Megumi Nakajo, and Ichiro Sonaka, and Kiwamu Okita
MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression.
June 2018, Cell death & disease,
Takashi Horie, and Isao Sakaida, and Fumihiko Yokoya, and Megumi Nakajo, and Ichiro Sonaka, and Kiwamu Okita
Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis.
April 2021, Journal of cellular and molecular medicine,
Takashi Horie, and Isao Sakaida, and Fumihiko Yokoya, and Megumi Nakajo, and Ichiro Sonaka, and Kiwamu Okita
Ivermectin Attenuates CCl4-Induced Liver Fibrosis in Mice by Suppressing Hepatic Stellate Cell Activation.
December 2022, International journal of molecular sciences,
Takashi Horie, and Isao Sakaida, and Fumihiko Yokoya, and Megumi Nakajo, and Ichiro Sonaka, and Kiwamu Okita
MicroRNA-195-3p promotes hepatic stellate cell activation and liver fibrosis by suppressing PTEN expression.
February 2022, Toxicology letters,
Takashi Horie, and Isao Sakaida, and Fumihiko Yokoya, and Megumi Nakajo, and Ichiro Sonaka, and Kiwamu Okita
miR-455-3p Alleviates Hepatic Stellate Cell Activation and Liver Fibrosis by Suppressing HSF1 Expression.
June 2019, Molecular therapy. Nucleic acids,
Copied contents to your clipboard!